15 Jul What Pharmaceutical Companies Should Know Before Expanding Into International Markets
Expanding a pharmaceutical business into new international markets is one of the most promising ways to grow revenue and reach patients who need treatments that are not yet available where they live. It is also one of the most complicated types of expansion a company can attempt. Pharmaceutical products are held to a different standard than nearly any other category of goods, and every country a company enters brings its own regulatory framework, documentation requirements, and approval timelines.
Companies that plan carefully before expanding tend to move faster and avoid costly setbacks. Companies that treat international expansion as a simple logistics exercise often run into problems that could have been avoided with proper preparation. Here is what pharmaceutical companies should understand before taking their products into new markets, explained in enough detail to actually help with planning. The regulatory complexity involved in global submissions is also explored in this overview of how pharmaceutical companies support global regulatory submissions through specialized testing.
[caption id="attachment_75012" align="aligncenter" width="500"] Photo by www.kaboompics.com[/caption]